Literature DB >> 6128531

Peptic ulcer healing with ranitidine in cimetidine resistance.

L Witzel, E Wolbergs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1982        PMID： 6128531     DOI： 10.1016/s0140-6736(82)91247-8

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  4 in total

1.  The refractory ulcer.

Authors:  D W Piper
Journal:  World J Surg       Date:  1987-06       Impact factor: 3.352

2.  Refractory duodenal ulcer.

Authors:  K D Bardhan
Journal:  Gut       Date:  1984-07       Impact factor: 23.059

Review 3.  Ranitidine. An updated review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in peptic ulcer disease and other allied diseases.

Authors:  S M Grant; H D Langtry; R N Brogden
Journal:  Drugs       Date:  1989-06       Impact factor: 9.546

4.  Tripotassium dicitrato bismuthate (TDB) versus two different dosages of cimetidine in the treatment of resistant duodenal ulcers.

Authors:  G Bianchi Porro; F Parente; M Lazzaroni
Journal:  Gut       Date:  1987-07       Impact factor: 23.059
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.